Using single-cell proteogenomics to fight multiple myeloma ?
Presently one the organization has willingly volunteered to improve accuracy drug utilizing
single-cell examination: Proteome. Among its first targets are blood malignant
growths, for example, various myeloma. As one of the most forceful blood
tumors, the treatment of different myeloma accompanies various difficulties.
"Myeloma is
an extremely troublesome malady to treat since it always backslides,"
clarifies Chng Wee Joo, Senior Consultant and Head of Department of
Hematology-Oncology at the National University Cancer Institute Singapore.
"The tumor cells are exceptionally heterogeneous, and the resistant
microenvironment likewise assumes a significant job, making extra multifaceted
nature. Ordinarily, patients are treated with different medications simultaneously,
which triggers reactions and is amazingly exorbitant. There is unquestionably a
requirement for better accuracy medication here."
Comments
Post a Comment